The Calcium Channel Blocker Bepridil Demonstrates Efficacy in the Murine Model of Marburg Virus Disease

被引：19

作者：

DeWald, Lisa Evans ^{[1
,3
]}

Dyall, Julie ^{[1
]}

Sword, Jennifer M. ^{[1
]}

Torzewski, Lisa ^{[1
]}

Zhou, Huanying ^{[1
]}

Postnikova, Elena ^{[1
]}

Kollins, Erin ^{[1
]}

Alexander, Isis ^{[1
]}

Gross, Robin ^{[1
]}

Cong, Yu ^{[1
]}

Gerhardt, Dawn M. ^{[1
]}

Johnson, Reed F. ^{[2
]}

Olinger, Gene G., Jr. ^{[1
,4
]}

Holbrook, Michael R. ^{[1
]}

Hensley, Lisa E. ^{[1
]}

Jahrling, Peter B. ^{[1
,2
]}

机构：

[1] NIAID, Integrated Res Facil, NIH, B-8200 Res Plaza, Frederick, MD 21702 USA

[2] NIAID, Emerging Viral Pathogens Sect, NIH, Frederick, MD USA

[3] Emergent BioSolut Inc, Gaithersburg, MD USA

[4] MRIGlobal Global Hlth Surveillance & Diagnost, Gaithersburg, MD USA

来源：

JOURNAL OF INFECTIOUS DISEASES | 2018年 / 218卷

关键词：

antiviral; bepridil; Marburg virus; GLYCOPROTEIN; AMIODARONE; TARGET; EBOLA;

D O I：

10.1093/infdis/jiy332

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

No therapeutics are approved for the treatment of filovirus infections. Bepridil, a calcium channel blocker developed for treating angina, was identified as a potent inhibitor of filoviruses in vitro, including Ebola and Marburg viruses, and Ebola virus in vivo. We evaluated the efficacy of bepridil in a lethal mouse model of Marburg virus disease. A dose of 12 mg/kg bepridil once or twice daily resulted in 80% or 90% survival, respectively. These data confirm bepridil's broad-spectrum anti-filovirus activity warranting further investigation of bepridil, or improved compounds with a similar mechanism, as a pan-filovirus therapeutic agent.

引用

页码：S588 / S591

页数：4

共 50 条

[41] EFFICACY AND SAFETY OF FELODIPINE, A NEW DIHYDROPYRIDINE CALCIUM-CHANNEL BLOCKER, IN ELDERLY HYPERTENSIVE PATIENTS
DEQUATTRO, V
CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE, 1992, 14 (06) : 965 - 988
[42] Efficacy of combination therapy with angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertension
Redon, Josep
Trenkwalder, Peter R. A.
Barrios, Vivencio
EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (02) : 155 - 164
[43] A disubstituted succinamide is a potent sodium channel blocker with efficacy in a rat pain model
Priest, BT
Garcia, ML
Middleton, RE
Brochu, RM
Clark, S
Dai, G
Dick, IE
Felix, JP
Liu, CJ
Reiseter, BS
Schmalhofer, WA
Shao, PCP
Tang, YS
Chou, MZ
Kohler, MG
Smith, MM
Warren, VA
Williams, BS
Cohen, CJ
Martin, WJ
Meinke, PT
Parsons, WH
Wafford, KA
Kaczorowski, GJ
BIOCHEMISTRY, 2004, 43 (30) : 9866 - 9876
[44] Intralesional injection of the calcium channel blocker Verapamil in Peyronie's disease: A critical review
Asali, Murad
Asali, Muhammad
ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, 2020, 92 (03) : 253 - 258
[45] Single-Dose Calcium Channel Blocker Toxicity in a Patient With Severe Liver Disease
Lodha, Shweta
Loriaux, Daniel
Faulkner, Amanda L.
Pearson, Kathyrn
Shah, Shreyansh
CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
[46] Calcium channel blocker use and risk of Parkinson's disease: a meta-analysis
Lang, Yakun
Gong, Dandan
Fan, Yu
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 (06) : 559 - 566
[47] No association between calcium channel blocker use and confirmed bleeding peptic ulcer disease
Smalley, WE
Ray, WA
Daugherty, JR
Griffin, MR
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1998, 148 (04) : 350 - 354
[48] USE OF A CALCIUM-CHANNEL BLOCKER (NICARDIPINE HCL) IN THE TREATMENT OF CHILDHOOD MOYAMOYA DISEASE
HOSAIN, SA
HUGHES, JT
FOREM, SL
WISOFF, J
FISH, I
JOURNAL OF CHILD NEUROLOGY, 1994, 9 (04) : 378 - 380
[49] Impaired Function of Circulating Cd34+Cd45- Cells in Patients with Persistent Atrial Fibrillation Is Restored by the Calcium Channel Blocker Bepridil Hydrochloride
Katoh, Youichi
Hashimoto, Ryota
Yozu, Gakuto
Yu-u, Hiroshige
Yamase, Miki
Enjyoji, Yoshihisa
Nakazato, Yuji
CIRCULATION RESEARCH, 2012, 111 (04)
[50] Association of calcium channel blocker use with lower hemoglobin levels in chronic kidney disease
Cikrikcioglu, M. A.
Karatoprak, C.
Cakirca, M.
Kiskac, M.
Zorlu, M.
Cetin, G.
Yildiz, K.
Erkoc, R.
Alay, M.
Erkal, S.
Erkal, S. N.
Dogan, S.
Kazancioglu, R.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2013, 17 (18) : 2530 - 2537

← 1 2 3 4 5 →